Skip to main content
Livermore
Livermore
ZHEN

Qube Research & Technologies Ltd

SEC CIK
0001729829
Latest filing
Aug 14, 2026

UTHR holding history

United Therapeutics Corp in every 13F filed by Qube Research & Technologies Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

UTHR overviewAll 13F holders of UTHRFull Q2 2026 holdings

Shares (Q2 2026)
233,639
Value
$126.6M
% of portfolio
0.1%
Quarters held
20
Since Q1 2021
Holdings of UTHR by Qube Research & Technologies Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026233,639$126.6M0.1%+110,198+89.3%AddedHolders
Q1 2026123,441$73.2M0.1%+25,137+25.6%AddedHolders
Q4 202598,304$47.9M0.1%+68,705+232.1%AddedHolders
Q3 202529,599$12.4M<0.1%−121,496−80.4%ReducedHolders
Q2 2025151,095$43.4M0.1%−31,495−17.2%ReducedHolders
Q1 2025182,590$56.3M0.1%+72,247+65.5%AddedHolders
Q4 2024110,343$38.9M0.1%+56,530+105.0%AddedHolders
Q3 202453,813$19.3M<0.1%+22,118+69.8%AddedHolders
Q2 202431,695$10.1M<0.1%−152,962−82.8%ReducedHolders
Q1 2024184,657$42.4M0.1%−20,587−10.0%ReducedHolders
Q4 2023205,244$45.1M0.1%+121,279+144.4%AddedHolders
Q3 202383,965$19.0M0.1%+4,245+5.3%AddedHolders
Q2 202379,720$17.6M0.1%−96,447−54.7%ReducedHolders
Q1 2023176,167$39.5M0.2%+31,211+21.5%AddedHolders
Q4 2022144,956$40.3M0.2%+77,946+116.3%AddedHolders
Q3 202267,010$14.0M0.1%+67,010NewHolders
Q2 20220$00.0%−15,557−100.0%Sold outHolders
Q1 202215,557$2.79M<0.1%+15,557NewHolders
Q4 20210$00.0%−66,113−100.0%Sold outHolders
Q3 202166,113$12.2M0.2%+51,904+365.3%AddedHolders
Q2 202114,209$2.55M<0.1%+6,505+84.4%AddedHolders
Q1 20217,704$1.29M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.